Pain AND Opioids After Surgery

NCT05877157 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2024-12-24

No results posted yet for this study

Summary

The aim of this study is to document the perioperative opioid use and its safety in the UK and countries in Europe and to describe its association with surgical complications, persistent pain and quality of life. In an international, prospective, observational cohort study, data about the perioperative pain management will be collected in all eligible hospitalised adult patients who undergo surgery in a designated "study week" in as many hospitals as possible in Europe. Baseline data will be collected, and participants followed up at one week, and at three and twelve months post-operatively. The primary outcome will be opioid use at three months after surgery. Secondary outcomes will include opioid use during the preoperative month (preoperative use), during surgery and up to one week after surgery (or discharge, whichever is earlier), and up to the end of the postoperative year. Additional secondary outcomes are the incidence of preoperative pain, persistent pain with/without the presence of neuropathic components, quality of life and surgical complications. The potential association between opioid use and pain outcomes will be investigated. This study could help to develop strategies to improve quality of care, through pain management, for patients undergoing surgery.

Conditions

  • Opioid Use
  • Pain, Chronic
  • Pain, Postoperative
  • Quality of Life

Sponsors & Collaborators

  • European Society of Anaesthesiology and Intensive Care

    collaborator OTHER
  • University of Aberdeen

    lead OTHER

Principal Investigators

  • Patrice Forget · University of Aberdeen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-25
Primary Completion
2026-05-30
Completion
2026-09-30

Countries

  • Croatia
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05877157 on ClinicalTrials.gov